C38H30ClF3N12O7 — CID 166611733
4-[4-[[4-[(6-chloro-2-methylindazol-5-yl)amino]-2,6-dioxo-3-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazin-1-yl]methyl]triazol-1-yl]-N-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]butanamide (PubChem CID 166611733) has the molecular formula C38H30ClF3N12O7 and a molecular weight of 859.18 g/mol. Its IUPAC name is 4-[4-[[4-[(6-chloro-2-methylindazol-5-yl)amino]-2,6-dioxo-3-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazin-1-yl]methyl]triazol-1-yl]-N-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]butanamide.
| Compound Name | 4-[4-[[4-[(6-chloro-2-methylindazol-5-yl)amino]-2,6-dioxo-3-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazin-1-yl]methyl]triazol-1-yl]-N-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]butanamide |
|---|---|
| PubChem CID | 166611733 |
| Molecular Formula | C38H30ClF3N12O7 |
| Molecular Weight | 859.18 g/mol |
| Exact Mass | 858.20 |
| IUPAC Name | 4-[4-[[4-[(6-chloro-2-methylindazol-5-yl)amino]-2,6-dioxo-3-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazin-1-yl]methyl]triazol-1-yl]-N-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]butanamide |
| SMILES | Cn1cc2cc(Nc3nc(=O)n(Cc4cn(CCCC(=O)Nc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)nn4)c(=O)n3Cc3cc(F)c(F)cc3F)c(Cl)cc2n1 |
| InChI | InChI=1S/C38H30ClF3N12O7/c1-50-14-19-11-28(22(39)12-27(19)48-50)44-36-46-37(60)53(38(61)52(36)15-18-10-24(41)25(42)13-23(18)40)17-20-16-51(49-47-20)9-3-6-30(55)43-26-5-2-4-21-32(26)35(59)54(34(21)58)29-7-8-31(56)45-33(29)57/h2,4-5,10-14,16,29H,3,6-9,15,17H2,1H3,(H,43,55)(H,44,46,60)(H,45,56,57) |
| InChIKey | OKSDXABBDHCBNZ-UHFFFAOYSA-N |
| XLogP | 2.61 |
| TPSA | 230.10 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 61 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 859.18 |
| LogP ≤ 5 | 2.61 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 16 |
| Structural Alerts | {'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|